HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis (Q34554560)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis (English)

1 reference

Europe PubMed Central

3 August 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

9

object named as

Jens Lundgren

1 reference

Europe PubMed Central

3 August 2017

Antonella d'Arminio Monforte

14

object named as

Antonella d'Arminio Monforte

1 reference

Europe PubMed Central

3 August 2017

Gerd Fätkenheuer

12

object named as

Gerd Fätkenheuer

1 reference

Europe PubMed Central

3 August 2017

Dominique Costagliola

3

object named as

Dominique Costagliola

1 reference

Europe PubMed Central

3 August 2017

Schlomo Staszewski

13

object named as

Schlomo Staszewski

1 reference

Europe PubMed Central

3 August 2017

object named as

Caroline A Sabin

4

0 references

François Dabis

7

object named as

François Dabis

1 reference

Europe PubMed Central

3 August 2017

10

object named as

Robert S Hogg

1 reference

Europe PubMed Central

3 August 2017

Andrew N Phillips

5

object named as

Andrew N Phillips

1 reference

Europe PubMed Central

3 August 2017

6

object named as

Amy C Justice

1 reference

Europe PubMed Central

3 August 2017

Jonathan Sterne

2

object named as

Jonathan A C Sterne

1 reference

Europe PubMed Central

3 August 2017

author name string

John Gill

8

1 reference

Europe PubMed Central

3 August 2017

Frank de Wolf

11

1 reference

Europe PubMed Central

3 August 2017

Matthias Egger

15

1 reference

Europe PubMed Central

3 August 2017

Antiretroviral Therapy (ART) Cohort Collaboration

16

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

368

1 reference

Europe PubMed Central

3 August 2017

9534

1 reference

Europe PubMed Central

3 August 2017

451-458

1 reference

Europe PubMed Central

3 August 2017

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Physician specialization and the quality of care for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Migration and HIV epidemic in Greece

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological changes in AIDS and HIV infection in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Foci of tuberculosis transmission in central Los Angeles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Newly diagnosed HIV infections: review in UK and Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69152-6

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34554560&oldid=1750894821"